GGrantIndex
← Leaderboards

David Morse Livingston

Dana-Farber Cancer Institute

Google Scholar ↗PubMed ↗ORCID ↗
$29,482,838
Attributed
$29,482,838
Total exposure
14
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.5M · FY2005–21
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$65,304,527 · 15

By mechanism

P01$47,942,847 · 8
R01$6,293,236 · 2
R37$3,995,792 · 1
U01$3,910,512 · 1
R35$2,951,941 · 1
P50$210,199 · 2

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Proteins”

Research focus

ProteinsTumorMalignant NeoplasmsCellsBrca1 GeneBiochemicalTumor Suppressor GenesBaseBreastDna DamageComplexMalignant Breast NeoplasmInheritedOncoproteinsDna RepairCell CycleResponseNeoplasm /Cancer GeneticsGenesNuclearLaboratory MouseBinding ProteinsLearningEvent

Grant awards (89)

Deciphering the mechanism underlying BRCA1 breast cancer development$1,053,423
R35 · FY2021 · CA · contact PI
Deciphering the mechanism underlying BRCA1 breast cancer development$1,053,423
R35 · FY2020 · CA · contact PI
Deciphering the mechanism underlying BRCA1 breast cancer development$845,095
R35 · FY2019 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$499,987
R01 · FY2019 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$515,452
R01 · FY2018 · CA · contact PI
In Vivo Analysis of the BRCA1 Breast Cancer Development Pathway$426,385
P01 · FY2018 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$73,692
R01 · FY2018 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$515,452
R01 · FY2017 · CA · contact PI
In Vivo Analysis of the BRCA1 Breast Cancer Development Pathway$426,526
P01 · FY2017 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$33,820
R01 · FY2017 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$515,452
R01 · FY2016 · CA · contact PI
In Vivo Analysis of the BRCA1 Breast Cancer Development Pathway$426,399
P01 · FY2016 · CA · contact PI
In Vivo Analysis of the BRCA1 Breast Cancer Development Pathway$427,384
P01 · FY2015 · CA · contact PI
In Vivo Analysis of the BRCA1 Breast Cancer Development Pathway$436,738
P01 · FY2014 · CA · contact PI
Papova Virus Transforming Mechanisms$2,591,772
P01 · FY2013 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$480,837
R01 · FY2013 · CA · contact PI
BRCA 1 and 2 and Breast Cancer Development$435,222
P01 · FY2013 · CA · contact PI
Viral Oncoprotein Inhibition of Quiescence$413,849
P01 · FY2013 · CA · contact PI
Administrative Core$37,384
P01 · FY2013 · CA · contact PI
Papova Virus Transforming Mechanisms$2,776,746
P01 · FY2012 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$511,599
R01 · FY2012 · CA · contact PI
BRCA 1 and 2 and Breast Cancer Development$465,065
P01 · FY2012 · CA · contact PI
Viral Oncoprotein Inhibition of Quiescence$443,218
P01 · FY2012 · CA · contact PI
Administrative Core$40,064
P01 · FY2012 · CA · contact PI
Papova Virus Transforming Mechanisms$2,796,876
P01 · FY2011 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$511,671
R01 · FY2011 · CA · contact PI
BRCA 1 and 2 and Breast Cancer Development$467,354
P01 · FY2011 · CA · contact PI
Viral Oncoprotein Inhibition of Quiescence$446,252
P01 · FY2011 · CA · contact PI
Administrative Core$40,364
P01 · FY2011 · CA · contact PI
Papova Virus Transforming Mechanisms$2,890,965
P01 · FY2010 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$525,558
R01 · FY2010 · CA · contact PI
BRCA 1 and 2 and Breast Cancer Development$485,084
P01 · FY2010 · CA · contact PI
Viral Oncoprotein Inhibition of Quiescence$461,334
P01 · FY2010 · CA · contact PI
Administrative Core$41,752
P01 · FY2010 · CA · contact PI
Papova Virus Transforming Mechanisms$2,829,494
P01 · FY2009 · CA · contact PI
BRCA 1 and 2 and Breast Cancer Development$487,103
P01 · FY2009 · CA · contact PI
Viral Oncoprotein Inhibition of Quiescence$451,758
P01 · FY2009 · CA · contact PI
BRCA1 Function in Post-Damage Nuclear Foci$443,843
R01 · FY2009 · CA · contact PI
Biology and treatment of Brca1-Associated and Sporadic Basal-Like cancers$132,555
P50 · FY2009 · CA · contact PI
Administrative Core$40,909
P01 · FY2009 · CA · contact PI
Papova Virus Transforming Mechanisms$2,727,835
P01 · FY2008 · CA · contact PI
BRCA1 Functional Analysis$511,805
P01 · FY2008 · CA · contact PI
SV40 T/t Interactions with Pocket Proteins$417,085
P01 · FY2008 · CA · contact PI
BRCA1 and the Inactive X Chromosome$329,983
R01 · FY2008 · CA · contact PI
Biology and treatment of Brca1-Associated and Sporadic Basal-Like cancers$77,644
P50 · FY2008 · CA · contact PI
Papova Virus Transforming Mechanisms$2,712,408
P01 · FY2007 · CA · contact PI
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$564,298
R37 · FY2007 · CA · contact PI
BRCA1 Functional Analysis$509,464
P01 · FY2007 · CA · contact PI
SV40 T/t Interactions with Pocket Proteins$414,991
P01 · FY2007 · CA · contact PI
BRCA1 and the Inactive X Chromosome$328,874
R01 · FY2007 · CA · contact PI
Papova Virus Transforming Mechanisms$2,727,644
P01 · FY2006 · CA · contact PI
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$567,452
R37 · FY2006 · CA · contact PI
BRCA1 Functional Analysis$483,949
P01 · FY2006 · CA · contact PI
BRCA1 and the Inactive X Chromosome$331,053
R01 · FY2006 · CA · contact PI
SV40 T/t Interactions with Pocket Proteins$296,069
P01 · FY2006 · CA · contact PI
Papova Virus Transforming Mechanisms$2,662,357
P01 · FY2005 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$567,486
R37 · FY2005 · CA
BRCA1 Functional Analysis$472,326
P01 · FY2005 · CA
BRCA1 and the Inactive X Chromosome$331,420
R01 · FY2005 · CA
SV40 T/t Interactions with Pocket Proteins$288,975
P01 · FY2005 · CA
Papova Virus Transforming Mechanisms$2,586,191
P01 · FY2004 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$551,807
R37 · FY2004 · CA
BRCA1 Functional Analysis$449,403
P01 · FY2004 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER$424,817
U01 · FY2004 · CA
BRCA1 and the Inactive X Chromosome$344,543
R01 · FY2004 · CA
SV40 T/t Interactions with Pocket Proteins$280,953
P01 · FY2004 · CA
PAPOVA VIRUS TRANSFORMING MECHANISMS$2,201,979
P01 · FY2003 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER$827,400
U01 · FY2003 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$458,735
R37 · FY2003 · CA
PAPOVA VIRUS TRANSFORMING MECHANISMS$2,145,934
P01 · FY2002 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER$976,974
U01 · FY2002 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$447,643
R37 · FY2002 · CA
BRCA 1 ANALYSIS$291,807
P01 · FY2002 · CA
VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAY$228,401
P01 · FY2002 · CA
Functional testing for BRCA1 and BRCA2$0
P50 · FY2002 · CA
PAPOVA VIRUS TRANSFORMING MECHANISMS$2,091,515
P01 · FY2001 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER$826,761
U01 · FY2001 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$416,873
R37 · FY2001 · CA
BRCA 1 ANALYSIS$291,807
P01 · FY2001 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$14,500
R37 · FY2001 · CA
Functional testing for BRCA1 and BRCA2$0
P50 · FY2001 · CA
BRCA 1 ANALYSIS$0
P01 · FY2001 · CA
VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAY$0
P01 · FY2001 · CA
PAPOVA VIRUS TRANSFORMING MECHANISMS$2,079,973
P01 · FY2000 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER$854,560
U01 · FY2000 · CA
STRUCTURE AND FUNCTION OF SV40 NON-VIRION PROTEINS$406,998
R37 · FY2000 · CA
VIRAL ONCOPROTEIN PERTURBATION OF RB/E2F PATHWAY$283,979
P01 · FY2000 · CA
Functional testing for BRCA1 and BRCA2$0
P50 · FY2000 · CA
BRCA 1 ANALYSIS$0
P01 · FY2000 · CA